NCT02416908View on ClinicalTrials.gov

Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 16, 2015

Primary Completion Date

June 21, 2019

Study Completion Date

June 21, 2019

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Selinexor

DRUG

Cladribine

DRUG

G-CSF

DRUG

Cytarabine

PROCEDURE

Bone marrow biopsy

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors
All Listed Sponsors
collaborator

Karyopharm Therapeutics Inc

INDUSTRY

lead

Washington University School of Medicine

OTHER